BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edelmann J, Gribben JG. Obinutuzumab for the treatment of indolent lymphoma. Future Oncol 2016;12:1769-81. [PMID: 27117452 DOI: 10.2217/fon-2016-0084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Pejsa V, Lucijanic M, Jonjic Z, Prka Z, Vukorepa G. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia. Ann Hematol 2019;98:1509-10. [DOI: 10.1007/s00277-018-3552-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Houen G. Therapeutic Antibodies: An Overview. Methods Mol Biol 2022;2313:1-25. [PMID: 34478129 DOI: 10.1007/978-1-0716-1450-1_1] [Reference Citation Analysis]
3 Multani A, Ho DY. JC Polyomavirus Infection Potentiated by Biologics. Infect Dis Clin North Am 2020;34:359-88. [PMID: 32444013 DOI: 10.1016/j.idc.2020.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Juárez-Salcedo LM, Conde-Royo D, Quiroz-Cervantes K, Dalia S. Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature. Drugs Context 2020;9:2019-9-3. [PMID: 32426017 DOI: 10.7573/dic.2019-9-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Vidal-Crespo A, Matas-Céspedes A, Rodriguez V, Rossi C, Valero JG, Serrat N, Sanjuan-Pla A, Menéndez P, Roué G, López-Guillermo A, Giné E, Campo E, Colomer D, Bezombes C, van Bueren JL, Chiu C, Doshi P, Pérez-Galán P. Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens. Haematologica 2020;105:1032-41. [PMID: 31296574 DOI: 10.3324/haematol.2018.211904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]